Aberrant activity of AURKA facilitates tumorigenic transformation and progression through defective control of the mitotic spindle checkpoint in mammalian cells and in several types of human tumors, including breast cancer [11], colorectal cancer [8], myeloid leukemia [12] and hepatocellular carcinoma [13]. This evidence concerns the gene AURKA and breast cancer.